Patents by Inventor Sheena K. Aurora

Sheena K. Aurora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injection paradigm for administration of botulinum toxins
    Patent number: 11819541
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: November 21, 2023
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin, David W. Dodick
  • INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
    Publication number: 20210299232
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 11033610
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: June 15, 2021
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection Paradigm For Administration Of Botulinum Toxins
    Publication number: 20200000892
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: September 9, 2019
    Publication date: January 2, 2020
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 10406213
    Abstract: Methods for treating a patient suffering from a medication overuse headache disorder are provided. The methods comprise administering to a patient suffering from a medication overuse disorder a Clostridial toxin. The toxin is administered to the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles of the patient.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: September 10, 2019
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection Paradigm For Administration Of Botulinum Toxins
    Publication number: 20180028624
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: September 18, 2017
    Publication date: February 1, 2018
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 9764011
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: September 19, 2017
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
    Publication number: 20160175409
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 9279001
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: March 8, 2016
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 8968747
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: March 3, 2015
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 8936790
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: January 20, 2015
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
    Publication number: 20140030248
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: April 16, 2013
    Publication date: January 30, 2014
    Applicant: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Injection paradigm for administration of botulinum toxins
    Patent number: 8501195
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: August 6, 2013
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Mitchell F. Brin, Sheena K. Aurora, David W. Dodick
  • Injection Paradigm for Administration of Botulinum Toxins
    Publication number: 20120053126
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: March 30, 2011
    Publication date: March 1, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Catherine C. TURKEL, Mitchell F. Brin, Sheena K. Aurora, David W. Dodick
  • COMPOSITIONS AND METHODS FOR TREATING HEADACHE
    Publication number: 20110117070
    Abstract: Compositions and methods for the treatment of headaches, such as migraine and cluster headaches, comprising co-administration of a first therapeutic component comprising topiramate and a second therapeutic component comprising a therapeutically effective amount or mixture of one or more therapeutic agents selected from the group consisting of riboflavin, magnesium, coenzyme Q10, petasin, isopetasin, and parthenolide. Also disclosed are methods for increasing the efficacy, and reducing or preventing side effects, of topiramate treatment.
    Type: Application
    Filed: July 27, 2010
    Publication date: May 19, 2011
    Inventors: Sheena K. Aurora, Curt Hendrix
  • Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
    Patent number: 7910116
    Abstract: Methods for treating gastric disorders, such as GERD and delayed gastric emptying, by intramuscular administration of a botulinum toxin to a head, neck and/or shoulder muscle of a patient with a gastric disorder.
    Type: Grant
    Filed: August 24, 2005
    Date of Patent: March 22, 2011
    Assignee: Allergan, Inc.
    Inventor: Sheena K. Aurora